Convergent with these findings, Tsai et al. [48] demonstrated that the genetic variants of SERPINE1 gene (coding PAI-1) in humans may increase MDD susceptibility and decrease the acute therapeutic response to SSRIs. The gene discussed is SERPINE1; the disease is major depressive disorder.